{"SLR NAME":"Incidence and prognostic associations of myocardial injury in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis","References":[{"title1":"Cardiac Troponin I Is an Independent Predictor for Mortality in Hospitalized Patients With COVID-19","References":[{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.","References":[]},{"title2":"Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome.","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China [published online March 25, 2020].","References":[]}]},{"title1":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","References":[{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Coronavirus disease 2019 (covid-19) in Italy","References":[{"title3":"The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey"},{"title3":"Coronavirus Disease-2019 in cancer patients. A report of the first 25 cancer patients in a Western country (Italy)"},{"title3":"Cancer patients with COVID-19: a retrospective study of 51 patients in the district of Piacenza, Northern Italy"},{"title3":"Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates"},{"title3":"Adherence to COVID-19 vaccines in cancer patients: promote it and make it happen!"}]},{"title2":"Case-fatality rate and characteristics of patients dying in relation to covid-19 in Italy","References":[]},{"title2":"Severe outcomes among patients with coronavirus disease 2019 (covid-19) - United States, February 12-March 16, 2020","References":[{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"}]},{"title2":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, February 12-March 28, 2020","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19):United States, February 12-March 16, 2020."},{"title3":"Heart disease and stroke statistics:2020 update: a report from the American Heart Association."},{"title3":"Urban-rural county and state differences in chronic obstructive pulmonary disease:United States, 2015."}]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with covid-19 in the New York City area","References":[]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with covid-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (covid-19)","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Coronavirus infections: more than just the common cold"},{"title3":"Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Published December 31, 2019. Accessed January 31, 2020. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":" Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Published March 13, 2020. Accessed January 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected"},{"title3":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"A Novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Analysis on 54 mortality cases of coronavirus disease 2019 in the Republic of Korea from January 19 to March 10, 2020","References":[{"title3":"Report on the epidemiological features of coronavirus disease 2019 (COVID-19) outbreak in the Republic of Korea from January 19 to March 2, 2020"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) : China, 2020"}]},{"title2":"Covid-19 in critically ill patients in the Seattle Region - case series","References":[{"title3":"Novel coronavirus : China"},{"title3":"Coronavirus COVID-19 global cases"},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"2019 Novel coronavirus outbreak (COVID-19)"},{"title3":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Priorities for the US health community responding to COVID-19."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Coronavirus disease 2019 (COVID-19)"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome."},{"title3":"Prone positioning in severe acute respiratory distress syndrome."},{"title3":"Bacterial coinfection in influenza: a grand rounds review."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients."},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care."},{"title3":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement."}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","References":[]},{"title2":"NYC Health. Cases, hospitalizations and deaths. 2020. https://www1.nyc.gov/site/doh/covid/covid-19-data.page#download.","References":[]},{"title2":"Comparison of 3 Safety-Net Hospital Definitions and Association With Hospital Characteristics","References":[{"title3":"The experiences of Massachusetts hospitals as statewide health insurance reform was implemented"},{"title3":"An update on safety-net hospitals: coping with the late 1990s and early 2000s"},{"title3":"The influence of health policy and market factors on the hospital safety net"},{"title3":"US hospital industry restructuring and the hospital safety net"},{"title3":"The effect of changes in hospital reimbursement on nurse staffing decisions at safety net and nonsafety net hospitals"},{"title3":"Impact of nurse staffing mandates on safety-net hospitals: lessons from California"},{"title3":"How did safety-net hospitals cope in the 1990s?"},{"title3":"The impact of the Massachusetts health care reform on unpaid medical bills"},{"title3":"Hospital financial performance in the recent recession and implications for institutions that remain financially weak"},{"title3":"The effects of safety net hospital closures and conversions on patient travel distance to hospital services"},{"title3":"Differences in quality of care among non-safety-net, safety-net, and children's hospitals"},{"title3":"Population characteristics of markets of safety-net and non-safety-net hospitals"},{"title3":"Are urban safety-net hospitals losing low-risk Medicaid maternity patients?"},{"title3":"Quality of care in hospitals with a high percent of Medicaid patients"},{"title3":"Strained local and state government finances among current realities that threaten public hospitals' profitability"},{"title3":"Medicare's policy to limit payment for hospital-acquired conditions: the impact on safety net providers"},{"title3":"Erosion in the healthcare safety net: impacts on different population groups"},{"title3":"Facing the recession: how did safety-net hospitals fare financially compared with their peers?"},{"title3":"Based on key measures, care quality for Medicare enrollees at safety-net and non-safety-net hospitals was almost equal"},{"title3":"Quality of care for acute myocardial infarction at urban safety-net hospitals"},{"title3":"Failure to rescue in safety-net hospitals: availability of hospital resources and differences in performance"},{"title3":"Comparison of change in quality of care between safety-net and non-safety-net hospitals"},{"title3":"Patient experience in safety-net hospitals: implications for improving care and value-based purchasing"},{"title3":"California safety-net hospitals likely to be penalized by ACA value, readmission, and meaningful-use programs"},{"title3":"Evidence of an emerging digital divide among hospitals that care for the poor"},{"title3":"The effect of phase 2 of the Premier Hospital Quality Incentive Demonstration on incentive payments to hospitals caring for disadvantaged patients"},{"title3":"Disproportionate-share hospital payment reductions may threaten the financial stability of safety-net hospitals"},{"title3":"An evolving DSH payment"},{"title3":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies"},{"title3":"What is coefficient alpha? an examination of theory and applications"},{"title3":"Understanding the safety net: inpatient quality of care varies based on how one defines safety-net hospitals"},{"title3":"The relationship of financial and mission factors to the level of uncompensated care provided in California hospitals"}]},{"title2":"Generalized collinearity diagnostics","References":[]},{"title2":"Imdad MU, Aslam M. mctest: multicollinearity diagnostic measures version 1.2.5 2018. https://CRAN.R-project.org/package=mctest.","References":[]},{"title2":"A method for computing profile-likelihood based confidence intervals","References":[]},{"title2":"A proportional hazards model for the subdistribution of a competing risk","References":[]},{"title2":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","References":[]},{"title2":"Sfumato P. Goodness-of-fit for time-to-event data. 2020. https://www.rdocumentation.org/packages/goftte/versions/1.0.5.","References":[]},{"title2":"Melby C, Gu J, Rojanasakul M. Mapping New York City hospital beds as coronavirus cases surge. 2020 https://www.bloomberg.com/graphics/2020-new-york-coronavirus-outbreak-how-many-hospital-beds/.","References":[]},{"title2":"World Health Organization. Hospital beds (per 10 000 population). 2020 https://www.who.int/data/gho/data/indicators/indicator-details/GHO/hospital-beds-(per-10-000-population).","References":[]},{"title2":"Incidence and outcomes of acute lung injury","References":[{"title3":"Onco-nephrology: AKI in the cancer patient"},{"title3":"Acute renal failure in cancer patients"},{"title3":"Renal complications in oncologic patients"},{"title3":"Acute kidney injury in critically ill cancer patients: an update"},{"title3":"Risk factors for acute renal failure: inherent and modifiable risks"},{"title3":"The risk of acute renal failure in patients with chronic kidney disease"},{"title3":"Onconephrology: the latest frontier in the war against kidney disease"},{"title3":"Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival"},{"title3":"American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003"},{"title3":"Mechanisms of Cisplatin nephrotoxicity"},{"title3":"Routine administration of a single dose of cisplatin &gt;/= 75 mg/m2 after short hydration in an outpatient lung-cancer clinic"},{"title3":"Children's toxicology from bench to bed-Drug-induced renal injury (2): Nephrotoxicity induced by cisplatin and ifosfamide in children"},{"title3":"Does eGFR improve the diagnostic capability of S-Creatinine concentration results? A retrospective population based study"},{"title3":"Ten-year retrospective analysis of multiple trauma complicated by pulmonary contusion"},{"title3":"Evidence Underlying KDIGO (Kidney Disease: Improving Global Outcomes) Guideline Recommendations: A Systematic Review"},{"title3":"Non-small-cell lung cancer"},{"title3":"Toxicity and response criteria of the Eastern Cooperative Oncology Group"},{"title3":"Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients"},{"title3":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation"},{"title3":"Cisplatin nephrotoxicity: a review"},{"title3":"Stress response inhibits the nephrotoxicity of cisplatin"},{"title3":"Cisplatin nephrotoxicity: a multivariate analysis of potential predisposing factors"},{"title3":"Hydration with magnesium and mannitol without furosemide prevents the nephrotoxicity induced by cisplatin and pemetrexed in patients with advanced non-small cell lung cancer"},{"title3":"Risk factors for cisplatin-induced nephrotoxicity and potential of magnesium supplementation for renal protection"},{"title3":"Dose adjustment in renal impairment: response from AHFS Drug Information"}]},{"title2":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","References":[]},{"title2":"Sepsis and septic shock","References":[]},{"title2":"Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?","References":[]},{"title2":"The impact of influenza epidemics on hospitalizations","References":[]},{"title2":"Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008","References":[]},{"title2":"The pathophysiology and treatment of sepsis","References":[{"title3":"Epidemiology of severe sepsis around the world"},{"title3":"Rehospitalizations following sepsis: common and costly"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Actual incidence of global left ventricular hypokinesia in adult septic shock"},{"title3":"Incidence and significance of a positive troponin test in bacteremic patients without acute coronary syndrome"},{"title3":"Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response"},{"title3":"Septic cardiomyopathy: the value of lactoferrin and CD15 as specific markers to corroborate a definitive diagnosis"},{"title3":"Septic cardiomyopathy"},{"title3":"Sepsis-induced myocardial depression is associated with transcriptional changes in energy metabolism and contractile related genes: a physiological and gene expression-based approach"},{"title3":"Septic shock. Hemodynamics and pathogenesis"},{"title3":"Elevation of troponin I in sepsis and septic shock"},{"title3":"The cardiovascular response of normal humans to the administration of endotoxin"},{"title3":"Association of interleukin 8 and myocardial recovery in patients with ST-elevation myocardial infarction complicated by acute heart failure"},{"title3":"A retrospective observational study of the association between plasma levels of interleukin 8 in 42 patients with sepsis-induced myocardial dysfunction at a single center between 2017 and 2020"},{"title3":"Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction"},{"title3":"Endothelial NOS (NOS3) impairs myocardial function in developing sepsis"},{"title3":"Sepsis-induced cardiomyopathy: oxidative implications in the initiation and resolution of the damage"},{"title3":"Potential role of poly(adenosine 5'-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock"},{"title3":"Structural changes of the heart during severe sepsis or septic shock"},{"title3":"Mitochondrial mechanisms of sepsis-induced organ failure"},{"title3":"Profound but reversible myocardial depression in patients with septic shock"},{"title3":"Utilization of echocardiography during septic shock was associated with a decreased 28-day mortality: a propensity score-matched analysis of the MIMIC-III database"},{"title3":"Clinical impact and efficacy of bedside echocardiography on patient management in pediatric intensive care units (PICUs): a prospective study"},{"title3":"The relationship between transthoracic echocardiography and mortality in adult patients with multiple organ dysfunction syndrome: analysis of the MIMIC-III database"},{"title3":"Diastolic dysfunction and mortality in early severe sepsis and septic shock: a prospective, observational echocardiography study"},{"title3":"Role of echocardiography in reducing shock reversal time in pediatric septic shock: a randomized controlled trial"},{"title3":"Two-dimensional speckle tracking imaging detects impaired myocardial performance in children with septic shock, not recognized by conventional echocardiography"},{"title3":"Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction"},{"title3":"Speckle tracking echocardiography in patients with septic shock: a case control study (SPECKSS)"},{"title3":"Elevated troponin and myocardial infarction in the intensive care unit: a prospective study"},{"title3":"Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock"},{"title3":"Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis"},{"title3":"A review of sepsis-induced cardiomyopathy"},{"title3":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012"},{"title3":"Dobutamine administration in septic shock: addition to a standard protocol"},{"title3":"Elevation of systemic oxygen delivery in the treatment of critically ill patients"},{"title3":"Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial"},{"title3":"Levosimendan reduces mortality in patients with severe sepsis and septic shock: a meta-analysis of randomized trials"},{"title3":"Effects of intra-aortic balloon counterpulsation in a model of septic shock"}]},{"title2":"Acute pulmonary embolism and COVID-19 pneumonia: a random association?","References":[]},{"title2":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","References":[{"title3":"A novel coronavirus from patients with pneumonia in China. 2019"},{"title3":"WHO declares COVID-19 a Pandemic"},{"title3":"cdc.gov/coronavirus/2019.ncov"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Novel coronavirus: from discovery to clinical diagnostics"},{"title3":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis"},{"title3":"Pathologic findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Histopathologic changes and SARS-Cov-2 immunostaining in the lung of a patient with COVID-19"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Covid-19 does not lead to a &quot;Typical&quot; acute respiratory distress syndrome"},{"title3":"Degos disease: a C5b-9/interferon-alpha-mediated endotheliopathy syndrome"},{"title3":"The role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome"},{"title3":"Use of C4d as a diagnostic adjunct in lung allograft biopsies"},{"title3":"Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis"},{"title3":"A pathological report of three COVID-19 cases by minimally invasive autopsies"},{"title3":"Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS"},{"title3":"Degos disease: a C5b-9/interferon-alpha-mediated endotheliopathy syndrome"},{"title3":"Insights into the pathogenesis of catastrophic antiphospholipid syndrome. A case report of relapsing catastrophic antiphospholipid syndrome and review of the literature on ischemic colitis"},{"title3":"Typical and atypical hemolytic uremic syndrome in the critically Ill"},{"title3":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults"},{"title3":"The effects of Eculizumab on the pathology of malignant atrophic papulosis"},{"title3":"Anovel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways"},{"title3":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro"},{"title3":"Hematologic parameters in patients with COVID-19 infection"},{"title3":"Covid-19 in critically ill patients in the Seattle region-case series"},{"title3":"An approach to the patient with retiform purpura"},{"title3":"Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis"},{"title3":"Terminal complement complex (C5b-9) in children with recurrent hemolytic uremic syndrome"},{"title3":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy"},{"title3":"A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms"},{"title3":"The lectin pathway of complement and rheumatic heart disease"},{"title3":"Simultaneous activation of complement and coagulation by MBL-associated serine protease 2"},{"title3":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein"},{"title3":"Be on target: strategies of targeting alternative and lectin pathway components in complement-mediated diseases"},{"title3":"Imbalance between Angiotensin II - Angiotensin (1-7) system is associated with vascular endothelial dysfunction and inflammation in type 2 diabetes with newly diagnosed hypertension"},{"title3":"Complement activation in angiotensin II-induced organ damage"}]},{"title2":"Inflammatory cytokines in general and central obesity and modulating effects of physical activity","References":[{"title3":"World Health Organisation (WHO) Global Health Observatory (GHO). Available: http://www.who.int/gho/ncd/risk_factors/overweight/en/. Accessed 31 July 2014."},{"title3":"National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants"},{"title3":"Adipokines: inflammation and the pleiotropic role of white adipose tissue"},{"title3":"The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation"},{"title3":"Is type II diabetes mellitus a disease of the innate immune system"},{"title3":"Inflammation-sensitive plasma proteins are associated with future weight gain"},{"title3":"The association of asthma, nasal allergies, and positive skin prick tests with obesity, leptin, and adiponectin"},{"title3":"Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome"},{"title3":"Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease"},{"title3":"Recent advances in obesity-induced inflammation and insulin resistance"},{"title3":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization"},{"title3":"Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models"},{"title3":"T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance"},{"title3":"Adipose tissue-resident immune cells: key players in immunometabolism"},{"title3":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance"},{"title3":"Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss"},{"title3":"Serum IL-12 is increased in Mexican obese subjects and associated with low-grade inflammation and obesity-related parameters"},{"title3":"Increased levels of both Th1 and Th2 cytokines in subjects with metabolic syndrome (CURES-103)"},{"title3":"Association of low interleukin-10 levels with the metabolic syndrome in obese women"},{"title3":"Proinflammatory, anti-inflammatory cytokines and adiponkines in students with central obesity"},{"title3":"Obesity is associated with macrophage accumulation in adipose tissue"},{"title3":"TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population"},{"title3":"The endocrinology of exercise"},{"title3":"Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women"},{"title3":"Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity"},{"title3":"Evaluation of a portable device to measure daily energy expenditure in free-living adults"},{"title3":"Energy expenditure evaluation in humans and non-human primates by SenseWear Armband. Validation of energy expenditure evaluation by SenseWear Armband by direct comparison with indirect calorimetry"},{"title3":"Magnetic resonance imaging determined visceral fat reduction associates with enhanced IL-10 plasma levels in calorie restricted obese subjects"},{"title3":"Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss"},{"title3":"Hydrodynamic Delivery of mIL10 Gene Protects Mice From High-fat Diet-induced Obesity and Glucose Intolerance"},{"title3":"The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review"},{"title3":"Impact of physical activity on inflammation: effects on cardiovascular disease risk and other inflammatory conditions"},{"title3":"Associations of physical activity, cardiorespiratory fitness and fatness with low-grade inflammation in adolescents: the AFINOS Study"},{"title3":"Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects"},{"title3":"Effects of physical activity upon the liver"},{"title3":"Effects of exercise training on chronic inflammation in obesity. Current evidence and potential mechanisms"},{"title3":"The influence of cytokines on wakefulness regulation: clinical relevance, mechanisms and methodological problems"},{"title3":"Assessment of physical activity:a review of methodologies with reference to epidemiological research: a report of the exercise physiology section of the European Association of Cardiovascular Prevention and Rehabilitation"},{"title3":"Validation of the SenseWear Armband at high intensity exercise"},{"title3":"Validation of physical activity monitors in individuals with diabetes: energy expenditure estimation by the multisensor SenseWear Armband Pro3 and the step counter Omron HJ-720 against indirect calorimetry during walking"},{"title3":"Study to determine the criterion validity of the SenseWear Armband as a measure of physical activity in people with rheumatoid arthritis"},{"title3":"Evaluation of the SenseWear Mini Armband to Assess Energy Expenditure During Pole Walking"},{"title3":"Validity of a multi-sensor armband in estimating rest and exercise energy expenditure"},{"title3":"Accuracy of SenseWear Pro2 Armband to predict resting energy expenditure in childhood obesity"},{"title3":"Evaluation of a multisensor armband in estimating energy expenditure in obese individuals"},{"title3":"Energy expenditure by multisensor armband in overweight and obese lactating women validated by doubly labeled water"},{"title3":"Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113)"},{"title3":"Cytokine profiling of young overweight and obese female African American adults with prediabetes"},{"title3":"Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages"},{"title3":"Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function"},{"title3":"Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha"},{"title3":"Impact of obesity on IL-12 family gene expression in insulin responsive tissues"},{"title3":"Interferon-gamma and systemic autoimmunity"},{"title3":"Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma"},{"title3":"Association of polymorphism in the interferon gamma gene with IDDM"},{"title3":"Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation"},{"title3":"The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus"},{"title3":"Systemic inflammation and insulin sensitivity in obese IFN-gamma knockout mice"},{"title3":"The role of GM-CSF in adipose tissue inflammation"},{"title3":"GM-CSF action in the CNS decreases food intake and body weight"},{"title3":"Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells"},{"title3":"Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance"},{"title3":"Kruppel-like factor 4 regulates macrophage polarization"},{"title3":"Obesity and asthma: an association modified by age of asthma onset"},{"title3":"Sutherland. Obesity and asthma"},{"title3":"Obesity and asthma: an inflammatory disease of adipose tissue not the airway"},{"title3":"Pathology of asthma"},{"title3":"Interleukin-13: central mediator of allergic asthma"},{"title3":"Interleukin-3, -5, and granulocyte macrophage colony-stimulating factor induce adhesion and chemotaxis of human eosinophils via p38 mitogen-activated protein kinase and nuclear factor kappaB"},{"title3":"The relationship of inflammatory cytokines with asthma and obesity"},{"title3":"Asthma phenotypes: the evolution from clinical to molecular approaches"},{"title3":"Type 2 immune responses in obese individuals with asthma"},{"title3":"'Metabolically healthy obesity': origins and implications"},{"title3":"Benefits of the SenseWear armband over other physical activity measurements techniques"}]},{"title2":"Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue","References":[{"title3":"Immunological contributions to adipose tissue homeostasis"},{"title3":"Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states"},{"title3":"Macrophage-mediated inflammation in metabolic disease"},{"title3":"Defining macrophage phenotype and function in adipose tissue"},{"title3":"Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages"},{"title3":"A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha"},{"title3":"Macrophage-secreted factors induce adipocyte inflammation and insulin resistance"},{"title3":"Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins"},{"title3":"Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes"},{"title3":"Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes"},{"title3":"Stimulation of inflammatory gene expression in human preadipocytes by macrophage-conditioned medium: upregulation of IL-6 production by macrophage-derived IL-1beta"},{"title3":"Interleukin-1beta mediates macrophage-induced impairment of insulin signaling in human primary adipocytes"},{"title3":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance"},{"title3":"Inflammation and metabolic disorders"},{"title3":"Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity"},{"title3":"Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis"},{"title3":"Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes"},{"title3":"Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone"},{"title3":"Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects"},{"title3":"Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss"},{"title3":"Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro"},{"title3":"TGFbeta family members are key mediators in the induction of myofibroblast phenotype of human adipose tissue progenitor cells by macrophages"},{"title3":"Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients"},{"title3":"Association Between Specific Adipose Tissue CD4(+) T-Cell Populations and Insulin Resistance in Obese Individuals"},{"title3":"T cell-derived IL-22 amplifies IL-1beta-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes"},{"title3":"Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes"},{"title3":"Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression"},{"title3":"High fat diet induces formation of spontaneous liposarcoma in mouse adipose tissue with overexpression of interleukin 22"},{"title3":"Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes"},{"title3":"IL-17 regulates adipogenesis, glucose homeostasis, and obesity"},{"title3":"IL-17 inhibits adipogenesis in part via C/EBPalpha, PPARgamma and Kruppel-like factors"},{"title3":"Roles of chemokine ligand-2 (CXCL2) and neutrophils in influencing endothelial cell function and inflammation of human adipose tissue"},{"title3":"Endothelial cells from visceral adipose tissue disrupt adipocyte functions in a three-dimensional setting: partial rescue by angiopoietin-1"},{"title3":"Reggio, S. et al. Increased basement membrane components in adipose tissue during obesity: links with TGFbeta and metabolic phenotypes. J Clin Endocrinol Metab, jc20154304 (2016)."},{"title3":"Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte-activating factor/interleukin 1"},{"title3":"Weber, A., Wasiliew, P. &amp; Kracht, M. Interleukin-1beta (IL-1beta) processing pathway. Sci Signal 3, cm2 (2010)."},{"title3":"Mechanisms and functions of inflammasomes"},{"title3":"Inflammasomes: mechanism of action, role in disease, and therapeutics"},{"title3":"IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1beta by keratinocytes via the ROS-NLRP3-caspase-1 pathway"},{"title3":"Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss"},{"title3":"Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent"},{"title3":"Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms"},{"title3":"IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression"}]},{"title2":"Atherosclerosis and inflammation: overview and updates","References":[]},{"title2":"Report of the conference on low blood cholesterol: mortality associations","References":[]}]},{"title1":"Hospitalization and Mortality among Black Patients and White Patients with Covid-19","References":[{"title2":"COVID-19: cases in the US. Atlanta: Centers for Disease Control and Prevention, 2020 ().","References":[]},{"title2":"Characteristics of and important lessons from the coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention.","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy.","References":[]},{"title2":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 : United States, February 12-March 28, 2020.","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19):United States, February 12-March 16, 2020."},{"title3":"Heart disease and stroke statistics:2020 update: a report from the American Heart Association."},{"title3":"Urban-rural county and state differences in chronic obstructive pulmonary disease:United States, 2015."}]},{"title2":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19) : United States, February 12-March 16, 2020.","References":[{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"}]},{"title2":"Geographic differences in COVID-19 cases, deaths, and incidence : United States, February 12-April 7, 2020.","References":[{"title3":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19):United States, February 12-March 16, 2020."},{"title3":"COVID-19 in a long-term care facility:King County, Washington, February 27-March 9, 2020."},{"title3":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019:United States, February 12-March 28, 2020."},{"title3":"Update: public health response to the coronavirus disease 2019 outbreak:United States, February 24, 2020."},{"title3":"Community mitigation guidelines to prevent pandemic influenza:United States, 2017."},{"title3":"Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza."},{"title3":"An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China."},{"title3":"Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility:King County, Washington, March 2020."}]},{"title2":". COVID-19 home page ().","References":[]},{"title2":". QuickFacts: Louisiana ().","References":[]},{"title2":". Facts &amp; statistics ().","References":[{"title3":"Parasites: evolutions neurobiologists"},{"title3":"Heavy metals, parasitologic and oxidative stress biomarker investigations in Heterotis niloticus from Lekki Lagoon, Lagos, Nigeria"},{"title3":"Using DNA barcoding to link cystacanths and adults of the acanthocephalan Polymorphus brevis in central Mexico"},{"title3":"Metallothioneins in aquatic invertebrates: their role in metal detoxification and their use as biomarkers"},{"title3":"Classification"},{"title3":"Classification of the Acanthocephala"},{"title3":"Revision of Neoechinorhynchus Stiles &amp; Hassall, 1905 (Acanthocephala: Neoechinorhynchidae) with keys to 88 species in two subgenera"},{"title3":"Evaluating energy dispersive X-ray analysis (EDXA) as a diagnostic tool in acanthocephalan taxonomy as evidenced in Palaeacanthocephala and Archiacanthocephala"},{"title3":"Acanthocephalans from fishes and amphibians in Vietnam, with descriptions of five new species"},{"title3":"SEM study of hooks in the Acanthocephala with emphasis on structural-functional relationships"},{"title3":"Vicariance in a generalist fish parasite driven by climate and salinity tolerance of hosts"},{"title3":"The importance of biobanking in molecular taxonomy, with proposed definitions for vouchers in a molecular context"},{"title3":"Morphology, performance and attachment function in Corynosoma spp. (Acanthocephala)"},{"title3":"Diverse applications of environmental DNA methods in parasitology"},{"title3":"Multiple isotope analyses of the piketapeworm Triaenophorus nodulosus reveal peculiarities in consumer-dietdiscrimination patterns"},{"title3":"A life cycle database for parasitic acanthocephalans, cestodes, and nematodes"},{"title3":"Life-cycle complexity in helminths: What are the benefits?"},{"title3":"Detection of a new non-native freshwater species by DNA metabarcoding of environmental samples - first record of Gammarus fossarum in the UK"},{"title3":"Pollution and parasitism in aquatic animals: a meta-analysis of effect size"},{"title3":"Parasite life-cycle studies: a plea to resurrect an old parasitological tradition"},{"title3":"Divergent location of ribosomal genes in chromosomes of fish thorny-headed worms, Pomphorhynchus laevis and Pomphorhynchus tereticollis (Acanthocephala)"},{"title3":"Telomere analysis of platyhelminths and acanthocephalans by FISH and Southern hybridization"},{"title3":"Parasites and the neuroendocrine control of fish intestinal function: an ancient struggle between pathogens and host"},{"title3":"Bioaccumulation of six PCB indicator congeners in a heavily polluted water reservoir in Eastern Slovakia: tissue-specific distribution in fish and their parasites"},{"title3":"Parasitism and host sensitivity to cadmium: an acanthocephalan infection of the freshwater amphipod Gammarus pulex"},{"title3":"Morphological features as tools and as pitfalls in acanthocephalan systematics"},{"title3":"Les hotes des Acanthocephales I - Les Hotes intermediaires"},{"title3":"Parasite biodiversity faces extinction and redistribution in a changing climate"},{"title3":"Host-manipulation by parasites with complex life cycles: adaptive or not?"},{"title3":"Effects of the acanthocephalan Polymorphus minutus and the microsporidian Dictyocoela duebenum on energy reserves and stress response of cadmium exposed Gammarus fossarum"},{"title3":"Effect of hypoxia on the immune response of giant freshwater prawn Macrobrachium rosenbergii and its susceptibility to pathogen Enterococcus"},{"title3":"Effect of water temperature on the immune response of white shrimp Litopenaeus vannamei to Vibrio alginolyticus"},{"title3":"Dysbiosis of fish gut microbiota is associated with helminths parasitism rather than exposure to PAHs at environmentally relevant concentrations"},{"title3":"The origins and evolution of the Acanthocephala"},{"title3":"Immune depression induced by acanthocephalan parasites in their intermediate crustacean host: consequences for the risk of super-infection and links with host behavioural manipulation"},{"title3":"Parasite virulence when the infection reduces the host immune response"},{"title3":"A New Species of the Acanthocephalan Genus Filisoma (Cavisomidae) from Perciform Fishes in Rio de Janeiro, Brasil"},{"title3":"A minimalist macroparasite diversity in the round goby of the Upper Rhine reduced to an exotic acanthocephalan lineage"},{"title3":"Chromosomics: Bridging the gap between genomes and chromosomes"},{"title3":"Fish innate immunity against intestinal helminths"},{"title3":"Crustacean-acanthocephalan interaction and host cell-mediated immunity: parasite encapsulation and melanization"},{"title3":"Protection first then facilitation: A manipulative parasite modulates the vulnerability to predation of its intermediate host according to its own developmental stage"},{"title3":"Make visible the invisible: Optimized development of an environmental DNA metabarcoding tool for the characterization of trematode parasitic communities"},{"title3":"Phylogenomics and diversification of the Schistosomatidae based on Targeted Sequence Capture of Ultra-Conserved Elements"},{"title3":"Phylogenetic characterization of eukaryotic and prokaryotic gut flora of Nile tilapia, Oreochromis niloticus, along niches of Lake Nasser, Egypt, based on rRNA gene high-throughput sequences"},{"title3":"Invasive Ponto-Caspian amphipods and fish increase the distribution range of the acanthocephalan Pomphorhynchus tereticollis in the River Rhine"},{"title3":"Acanthocephalan parasites reflect ecological status of freshwater ecosystem"},{"title3":"Magnitude and direction of parasite-induced phenotypic alterations: a meta-analysis in acanthocephalans"},{"title3":"Effect of acanthocephalan infection on metal, total protein and metallothionein concentrations in European chub from a Sava River section with low metal contamination"},{"title3":"Does fish reproduction and metabolic activity influence metal levels in fish intestinal parasites, acanthocephalans, during fish spawning and post-spawning period?"},{"title3":"Parasite fauna of native and non-native populations of Neogobius melanostomus (Pallas, 1814) (Gobiidae) in the longitudinal profile of the Danube River"},{"title3":"Influence of the cestode Ligula intestinalis and the acanthocephalan Polymorphus minutus on levels of heat shock proteins (HSP70) and metallothioneins in their fish and crustacean intermediate hosts"},{"title3":"Patterns and processes influencing helminth parasites of Arctic coastal communities during climate change"},{"title3":"Mitochondrial phylogenomics of Acanthocephala: nucleotide alignments produce long-branch attraction artefacts"},{"title3":"First steps to understand the systematics of Echinorhynchidae Cobbold, 1876 (Acanthocephala), inferred through nuclear gene sequences"},{"title3":"Molecular identification and first description of the male of Neoechinorhynchus schmidti (Acanthocephala: Neoechinorhynchidae), a parasite of Trachemys scripta (Testudines) in Mexico"},{"title3":"Contrasting the population genetic structure of a specialist (Hexaglandula corynosoma: Acanthocephala: Polymorphidae) and generalist parasite (Southwellina hispida) distributed sympatrically in Mexico"},{"title3":"Genetic diversity and phylogeography of Corynosoma australe Johnston, 1937 (Acanthocephala: Polymorphidae), an endoparasite of otariids from the Americas in the northern and southern hemispheres"},{"title3":"Phylogenetic relationships of Acanthocephala based on analysis of 18S ribosomal RNA gene sequences"},{"title3":"Mitogenomic phylogeny of Acanthocephala reveals novel class relationships"},{"title3":"The ecological importance of amphipod-parasite associations for aquatic ecosystems"},{"title3":"You are how you eat. Differences in trophic levels of parasites infecting a single host according to stable isotopes"},{"title3":"Polymorphus minutus affects antitoxic responses of Gammarus roeseli exposed to cadmium"},{"title3":"Acanthocephalan parasites: help or burden in gammarid amphipods exposed to cadmium?"},{"title3":"Les hotes des Acanthocephales II - Les Hotes definitifs. 1. Poissons"},{"title3":"A new acanthocephalan species (Archiacanthocephala: Oligacanthorhynchidae) from the crab-eating fox (Cerdocyon thous) in the Brazilian Pantanal wetlands"},{"title3":"Phylogeography of a marine acanthocephalan: lack of cryptic diversity in a cosmopolitan parasite of mole crabs"},{"title3":"Excretory-secretory products of larval Fasciola hepatica investigated using a two-dimensional proteomic approach"},{"title3":"Amphipod parasites may bias results of ecotoxicological research"},{"title3":"Excretory-secretory proteome of larval Schistosoma mansoni and Echinostoma caproni, two parasites of Biomphalaria glabrata"},{"title3":"Infection and invasion: study cases from aquatic communities"},{"title3":"The syndermatan phylogeny and the evolution of acanthocephalan endoparasitism as inferred from 18S rDNA sequences"},{"title3":"Observations on the distribution, specificity and pathogenicity of the acanthocephalan Pomphorhynchus laevis (Muller)"},{"title3":"The population biology of the acanthocephalan Pomphorhynchus laevis (Muller) in the River Avon"},{"title3":"Pomphorhynchus laevis: An invasive species in the river Rhine?"},{"title3":"Effects of hypercapnic hypoxia on the clearance of Vibrio campbellii in the Atlantic blue crab, Callinectes sapidus Rathbun"},{"title3":"Molecular characterisation of acanthocephalans from Australian marine teleosts: proposal of a new family, synonymy of another and transfer of taxa between orders"},{"title3":"Comparative genomics of the major parasitic worms"},{"title3":"Host-manipulation by trophically transmitted parasites: The switcher-paradigm"},{"title3":"Does atypical 15N and 13C enrichment in parasites result from isotope ratio variation of host tissues they are infected?"},{"title3":"Optimizing phylogenomics with rapidly evolving long exons: Comparison with anchored hybrid enrichment and ultraconserved elements"},{"title3":"Integrative taxonomy reveals a new species of Dollfusentis (Acanthocephala: Illiosentidae), in Orthopristis ruber (Osteichthyes: Haemulidae) from Rio de Janeiro, Brazil"},{"title3":"Discontinuous distributions of the fish acanthocephalans Pomphorhynchus laevis and Acanthocephalus anguillae in Britain and Ireland: an hypothesis"},{"title3":"Systematic position of the genus Metacanthocephalus Yamaguti, 1959 (Palaeacanthocephala: Echinorhynchida) inferred from molecular evidence, with a redescription of Metacanthocephalus ovicephalus (Zhukov, 1960)"},{"title3":"Molecular identification of juvenile Neoechinorhynchus spp. (Phylum: Acanthocephala) infecting ostracod and snail hosts provides insight into acanthocephalan host use"},{"title3":"Host manipulation in the face of environmental changes: Ecological consequences"},{"title3":"Fish parasites as indicators of organic pollution in southern Brazil"},{"title3":"Environmental parasitology: what can parasites tell us about human impacts on the environment?"},{"title3":"Impacts of crustacean invasions on parasite dynamics in aquatic ecosystems: A plea for parasite-focused studies"},{"title3":"Effect of hypoxic stress on the immune response and the resistance to vibriosis of the shrimp Penaeus stylirostris"},{"title3":"Development of a PBPK model for silver accumulation in chub infected with acanthocephalan parasites"},{"title3":"What contributes to the metal-specific partitioning in the chub-acanthocephalan system?"},{"title3":"Accumulation of persistent organic pollutants in parasites"},{"title3":"Parasitism and environmental pollution: parasites and hosts as indicators of water quality"},{"title3":"Stress proteins (HSP's): methods of detection and their use as an environmental biomarker"},{"title3":"Morphological and molecular evidence for synonymy of Corynosoma obtuscens Lincicome, 1943 with Corynosoma australe Johnston, 1937 (Acanthocephala: Polymorphidae)"},{"title3":"Co-invaders: The effects of alien parasites on native hosts"},{"title3":"Phylogenetic relationships among Neoechinorhynchus species (Acanthocephala: Neoechinorhynchidae) from North-East Asia based on molecular data"},{"title3":"Detecting a complex of cryptic species within Neoechinorhynchus golvani (Acanthocephala: Neoechinorhynchidae) inferred from ITSs and LSU rDNA gene sequences"},{"title3":"The genome, transcriptome, and proteome of the fish parasite Pomphorhynchus laevis (Acanthocephala)"},{"title3":"Genomics and transcriptomics of epizoic Seisonidea (Rotifera, syn. Syndermata) reveal strain formation and gradual gene loss with growing ties to the host"},{"title3":"Lethal and sub-lethal effects of acid, aluminium and lime on Gammarus pulex during repeated simulated episodes in a Welsh stream"},{"title3":"The effect of the acanthocephalan Pomphorhynchus laevis (Muller 1776) on the acute toxicity of cadmium to its intermediate host, the amphipod Gammarus pulex (L.)"},{"title3":"Effects of acid, aluminium and lime additions on fish and invertebrates in a chronically acidic Welsh stream"},{"title3":"Parasite-induced changes in the diet of a freshwater amphipod: field and laboratory evidence"},{"title3":"Paratenic hosts as regular transmission route in the acanthocephalan Pomphorhynchus laevis: potential implications for food webs"},{"title3":"Potential benefits of acanthocephalan parasites for chub hosts in polluted environments"},{"title3":"Parasites in kelp-forest food webs increase food-chain length, complexity, and specialization, but reduce connectance"},{"title3":"Mitochondrial DNA dataset suggest that the genus Sphaerirostris Golvan, 1956 is a synonym of the genus Centrorhynchus Luhe, 1911"},{"title3":"Understanding trophic interactions in host-parasite associations using stable isotopes of carbon and nitrogen"},{"title3":"Environmental parasitology: Parasites as accumulation bioindicators in the marine environment"},{"title3":"Is metal accumulation in Pomphorhynchus laevis dependent on parasite sex or infrapopulation size?"},{"title3":"Phylogenetic relationships of the Acanthocephala inferred from 18S ribosomal DNA sequences"},{"title3":"Epizootiology"},{"title3":"Comparative cytogenetics in the genus Hoplias (Characiformes, Erythrinidae) highlights contrasting karyotype evolution among congeneric species"},{"title3":"Karyotype, chromosomal characteristics of multiple rDNA clusters and intragenomic variability of ribosomal ITS2 in Caryophyllaeides fennica (Cestoda)"},{"title3":"New cytogenetic data on Caryophyllaeus laticeps and Paracaryophyllaeus gotoi, parasites of evolutionary interest"},{"title3":"Investigating candidate neuromodulatory systems underlying parasitic manipulation: Concepts, limitations and prospects"},{"title3":"Differential patterns of definitive host use by two fish acanthocephalans occurring in sympatry: Pomphorhynchus laevis and Pomphorhynchus tereticollis"},{"title3":"Parasite-induced inversion of geotaxis in a freshwater amphipod: A role for anaerobic metabolism?"},{"title3":"Multidimensionality in host manipulation mimicked by serotonin injection"},{"title3":"Contrasting phylogeography of two Western Palaearctic fish parasites despite similar life cycles"},{"title3":"Evolutionary history and host ecology determine acanthocephalan egg shape"},{"title3":"A chromosome study of Schistocephalus solidus (Muller, 1776) (Cestoda: Pseudophyllidea)"},{"title3":"Mayarhynchus karlae ng, n. sp. (Acanthocephala: Neoechinorhynchidae), a parasite of cichlids (Perciformes: Cichlidae) in southeastern Mexico, with comments on the paraphyly of Neoechynorhynchus Stiles &amp; Hassall, 1905"},{"title3":"A hyper-diverse genus of acanthocephalans revealed by tree-based and non-tree-based species delimitation methods: Ten cryptic species of Neoechinorhynchus in Middle American freshwater fishes"},{"title3":"Description of a new species of Neoechinorhynchus (Acanthocephala: Neoechinorhynchidae) a parasite of Dormitator latifrons from Southwestern Mexico based on morphological and molecular characters"},{"title3":"Morphological and molecular data reveal a new species of Neoechinorhynchus (Acanthocephala: Neoechinorhynchidae) from Dormitator maculatus in the Gulf of Mexico"},{"title3":"Checklist of the species of Neoechinorhynchus (Acanthocephala: Neoechinorhynchidae) in fishes and turtles in Middle-America, and their delimitation based on sequences of the 28S rDNA"},{"title3":"Host condition and accumulation of metals by acanthocephalan parasite Echinorhynchus gadi in cod Gadus morhua from the southern Baltic Sea"},{"title3":"Investing in attachment: evolution of anchoring structures in acanthocephalan parasites"},{"title3":"Host manipulation by parasites: A look back before moving forward"},{"title3":"BOLD: The Barcode of Life Data system (http://www.barcodinglife.org)"},{"title3":"A DNA-based registry for all animal species: The Barcode Index Number (BIN) system"},{"title3":"Pseudocorynosoma enrietti (Molfi &amp; Freitas Fernandes, 1953) (Acanthocephala: Polymorphidae) from Patagonia (Argentina): life cycle, localities, and new host records"},{"title3":"An integrative taxonomic approach to reveal the status of the genus Pomphorhynchus Monticelli, 1905 (Acanthocephala: Pomphorhynchidae) in Austria"},{"title3":"Unravelling the hidden biodiversity - the establishment of DNA barcodes of fish parasitizing Acanthocephala Koehlreuther, 1771 in view of taxonomic misidentifications, intraspecific variability and possible cryptic species"},{"title3":"Differential phenoloxidase activity between native and invasive gammarids infected by local acanthocephalans: differential immunosuppression?"},{"title3":"Molecular phylogenetics of Floridosentis Ward, 1953 (Acanthocephala: Neoechinorhynchidae) parasites of mullets (Osteichthyes) from Mexico, using 28S rDNA sequences"},{"title3":"Genetic diversification of acanthocephalans of the genus Floridosentis Ward 1953 (Acanthocephala: Neoechinorhynchidae), parasites of mullets from the Americas"},{"title3":"Morphology, molecular characterization and phylogeny of Bolbosoma nipponicum Yamaguti, 1939 (Acanthocephala: Polymorphidae), a potential zoonotic parasite of human acanthocephaliasis"},{"title3":"Morphological and complete mitogenomic characterisation of the acanthocephalan Polymorphus minutus infecting the duck Anas platyrhynchos"},{"title3":"Characterization of ecto- and endoparasite communities of wild Mediterranean teleosts by a metabarcoding approach"},{"title3":"Development and life cycles"},{"title3":"Identification of antiparasitic drug targets using a multi-omics workflow in the acanthocephalan model"},{"title3":"Host-dependent impairment of parasite development and reproduction in the acanthocephalan model"},{"title3":"Parasites of freshwater fishes in North America: Why so neglected?"},{"title3":"Bridging the gap: aquatic parasites in the One Health concept"},{"title3":"Phenotypic plasticity, genetic structure and systematic position of Neoechinorhynchus emyditoides Fisher, 1960 (Acanthocephala: Neoechinorhynchidae): a parasite of emydid turtles from the Nearctic and Neotropical regions"},{"title3":"Economic costs of protistan and metazoan parasites to global mariculture"},{"title3":"Phylogeny of Syndermata (syn. Rotifera): mitochondrial gene oder verifies epizoic Seisonidea as sister to endoparasitic Acanthocephala within monophyletic Hemirotifera"},{"title3":"The genus Rhadinorhynchus (Acanthocephala: Rhadinorhynchidae) from marine fish in Australia with the description of four new species"},{"title3":"A modern approach to rotiferan phylogeny: combining morphological and molecular data"},{"title3":"Karyotype of Acanthocephalus lucii: the first record of supernumerary chromosomes in thorny-headed worms"},{"title3":"Resurrection of Pomphorhynchus tereticollis (Rudolphi, 1809) (Acanthocephala: Pomphorhynchidae) based on new morphological and molecular data"},{"title3":"Chromosome studies of Ichthyocotylurus platycephalus (Creplin, 1825) Odening 1969 with description of triploid variant and comparative karyology of the genus Ichthyocotylurus"},{"title3":"Cryptic speciation and patterns of phenotypic variation of a highly variable acanthocephalan parasite"},{"title3":"Pollution-induced heat shock protein expression in the amphipod Gammarus roeseli is affected by larvae of Polymorphus minutus (Acanthocephala)"},{"title3":"The intestinal parasite Pomphorhynchus laevis as a sensitive accumulation indicator for the platinum group metals Pt, Pd, and Rh"},{"title3":"Effects of multiple stressors in fish: how parasites and contaminants interact"},{"title3":"Parasite responses to pollution: what we know and where we go in &quot;Environmental Parasitology&quot;"},{"title3":"Analysis of trace metals in the Antarctic host-parasite system Notothenia coriiceps and Aspersentis megarhynchus (Acanthocephala) caught at King George Island, South Shetland Islands"},{"title3":"Parasites as accumulation indicators of heavy metal pollution"},{"title3":"Cadmium concentrations in two adult acanthocephalans, Pomphorhynchus laevis and Acanthocephalus lucii, as compared with their fish hosts and cadmium and lead levels in larvae of A. lucii as compared with their crustacean host"},{"title3":"Altered host behaviour and brain serotonergic activity caused by acanthocephalans: Evidence for specificity"},{"title3":"Differential influence of Pomphorhynchus laevis (Acanthocephala) on brain serotonergic activity in two congeneric host species"},{"title3":"Host-parasite interactions in acanthocephala: A morphological approach"},{"title3":"The intestinal parasite Pomphorhynchus laevis (Acanthocephala) from barbel as a bioindicator for metal pollution in the Danube River near Budapest, Hungary"},{"title3":"The effects of temperature and oxygen on the development of Polymorphus marilis (Acanthocephala) in Gammarus lacustris (Amphipoda)"},{"title3":"Eutrophication, pollution and fragmentation: effects on parasite communities in roach (Rutilus rutilus) and perch (Perca fluviatilis) in four lakes in central Finland"},{"title3":"Molecular characterisation and infection dynamics of Dentitruncus truttae from trout (Salmo trutta and Oncorhynchus mykiss) in Krka River, Croatia"},{"title3":"DNA metabarcoding quantifies the relative biomass of arthropod taxa in songbird diets: Validation with camera-recorded diets"},{"title3":"Molecular phylogeny of the Acanthocephala (class Palaeacanthocephala) with a paraphyletic assemblage of the orders Polymorphida and Echinorhynchida"},{"title3":"New determination of prey and parasite species for northern Indian Ocean blue whales"},{"title3":"The systematics of Echinorhynchus Zoega in Muller, 1776 (Acanthocephala, Echinorhynchidae) elucidated by nuclear and mitochondrial sequence data from eight European taxa"},{"title3":"Phylogenetic analyses of endoparasitic Acanthocephala based on mitochondrial genomes suggest secondary loss of sensory organs"},{"title3":"Transcriptome data reveal syndermatan relationships and suggest the evolution of endoparasitism in Acanthocephala via an epizoic stage"},{"title3":"Role of hypoxia in the behaviour, physiology, immunity and response mechanisms of crustaceans: A review"},{"title3":"Accumulation of the precious metals platinum, palladium and rhodium from automobile catalytic converters in Paratenuisentis ambiguus as compared with its fish host, Anguilla anguilla"}]},{"title2":". Uniform Data System Mapper ().","References":[]},{"title2":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","References":[]},{"title2":"How to measure comorbidity: a critical review of available methods.","References":[]},{"title2":"Association of patient social, cognitive, and functional risk factors with preventable hospitalizations: implications for physician value-based payment.","References":[]},{"title2":"Impact of overweight and obesity on hospitalization: race and gender differences.","References":[{"title3":"Prevalence and trends in obesity among US adults, 1999-2000"},{"title3":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001"},{"title3":"Prevalence of overweight and obesity in the United States, 1999-2004"},{"title3":"National medical spending attributable to overweight and obesity: how much, and who's paying?"},{"title3":"Current estimates of the economic cost of obesity in the United States"},{"title3":"Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults:The Evidence Report. National Institutes of Health"},{"title3":"Obesity and the use of health care services"},{"title3":"Hospital admissions associated with body mass index in Canadian adults"},{"title3":"Black and white chains of risk for hospitalization over 20 years"},{"title3":"The relationship of overweight and obesity with subjective health and use of health-care services among Spanish women"},{"title3":"Body mass index and hospitalization in the elderly"},{"title3":"Obesity, health services use, and health care costs among members of a Health Maintenance Organization"},{"title3":"Health services use and health care costs of obese and nonobese individuals"},{"title3":"Relationship between body mass index and the use of healthcare services in Australia"},{"title3":"Long-term obesity and avoidable hospitalization among younger, middle-aged, and older adults"},{"title3":"Obesity and hospitalization over the adult life course: does duration of exposure increase use?"},{"title3":"Utilization of health care resources by obese Canadians"},{"title3":"Midlife body mass index and hospitalization and mortality in older age"},{"title3":"Length of hospital stays among obese individuals"},{"title3":"Racial or ethnic differences in hospitalization for heart failure among elderly adults: Medicare, 1990-2000"},{"title3":"Gender and race as factors in health care utilization"},{"title3":"Addressing Racial and Ethnic Disparities in Health Care: Fact Sheet"},{"title3":"Differences in mortality and use of revascularization in black and white patients with acute MI admitted to hospitals with and without revascularization services"},{"title3":"Racial differences in cerebrovascular disease hospitalizations"},{"title3":"Hospitalization in the United States, 2002"},{"title3":"The Atherosclerosis Risk in Communities (ARIC) Study: Design and Objectives. The ARIC investigators"},{"title3":"Obesity: Preventing and Managing the Global Epidemic"},{"title3":"A short questionnaire for the measurement of habitual physical activity in epidemiological studies"},{"title3":"Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience"},{"title3":"Hospitalization in the United States, 2002"},{"title3":"Body weight and longevity. A reassessment"},{"title3":"Excess deaths associated with underweight, overweight, and obesity"},{"title3":"Annual deaths attributable to obesity in the United States"},{"title3":"Impact of overweight on the risk of developing common chronic diseases during a 10-year period"},{"title3":"Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study"},{"title3":"Overweight and obesity as determinants of cardiovascular risk: the Framingham experience"},{"title3":"Overweight is an independent risk factor for cardiovascular disease in Chinese populations"},{"title3":"Body fat distribution, obesity, overweight and stroke incidence in women and men:the NHANES I Epidemiologic Follow-up Study"},{"title3":"Body mass index and the risk of stroke in men"},{"title3":"Prospective study of body mass index and risk of stroke in apparently healthy women"},{"title3":"Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants"},{"title3":"Overweight as an avoidable cause of cancer in Europe"},{"title3":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults"},{"title3":"Obesity impacts on general practice appointments"},{"title3":"Bariatric surgeries in North Carolina, 1990-2001: a gender comparison"},{"title3":"Black-white differences in serum sex hormones and bone mineral density"},{"title3":"Ultrasound of the calcaneus and bone mineral density differs in older black and white women but is not impacted by current physical activity"},{"title3":"Body composition and gonadal steroids in older white and black women"},{"title3":"Measures of body composition in blacks and whites: a comparative review"},{"title3":"Selection of measures in epidemiologic studies of the consequences of obesity"},{"title3":"Health spending growth slows in 2003"},{"title3":"Healthcare Cost and Utilization Nationwide Inpatient Sample"}]},{"title2":"Multiple imputation of discrete and continuous data by fully conditional specification.","References":[]},{"title2":"Risk factors of critical &amp; mortal COVID-19 cases: a systematic literature review and meta-analysis.","References":[]},{"title2":"Characteristics and clinical outcomes of adult patients hospitalized with COVID-19 : Georgia, March 2020.","References":[{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"Research electronic data capture (REDCap):a metadata-driven methodology and workflow process for providing translational research informatics support."},{"title3":"Covid-19 in critically ill patients in the Seattle region:case series."},{"title3":"Community mitigation guidelines to prevent pandemic influenza:United States, 2017."},{"title3":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019:COVID-NET, 14 states, March 1-30, 2020."}]},{"title2":". 2018 Louisiana health report card ().","References":[]},{"title2":"Covid-19 in critically ill patients in the Seattle region : case series.","References":[{"title3":"Novel coronavirus : China"},{"title3":"Coronavirus COVID-19 global cases"},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"2019 Novel coronavirus outbreak (COVID-19)"},{"title3":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Priorities for the US health community responding to COVID-19."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Coronavirus disease 2019 (COVID-19)"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome."},{"title3":"Prone positioning in severe acute respiratory distress syndrome."},{"title3":"Bacterial coinfection in influenza: a grand rounds review."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients."},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care."},{"title3":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement."}]},{"title2":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State.","References":[]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area.","References":[]},{"title2":"Genetic ancestry and natural selection drive population differences in immune responses to pathogens.","References":[]},{"title2":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.","References":[]}]},{"title1":"Cardiac Injury Patterns and Inpatient Outcomes Among Patients Admitted With COVID-19","References":[{"title2":"Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU), Johns-Hopkins-University website. July 1, 2020.https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6. Accessed July 1, 2020.","References":[]},{"title2":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Coronavirus infections: more than just the common cold"},{"title3":"Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Published December 31, 2019. Accessed January 31, 2020. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":" Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Published March 13, 2020. Accessed January 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected"},{"title3":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"A Novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"}]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","References":[]},{"title2":"ACC CLINICAL BULLETIN COVID-19 Clinical Guidance For the CV Care Team, American College of Cardiology website. February 07, 2020.https://www.acc.org/~/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/2020/02/S20028-ACC-Clinical-Bulletin-Coronavirus.pdf. Accessed July 1, 2020.","References":[]},{"title2":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"CDC Diagnostic Test for COVID-19, Centers for Disease Control and Prevention website. June 2020.https://www.cdc.gov/coronavirus/2019-ncov/lab/testing.html. Accessed July 1, 2020.","References":[]},{"title2":"Radiological society of North America expert consensus statement on reporting chest CT findings related to COVID-19. endorsed by the society of thoracic radiology, the American college of radiology, and RSNA","References":[{"title3":"CT imaging features of 2019 Novel Coronavirus (2019-nCoV)"},{"title3":"Chest CT findings in Coronavirus Disease-19 (COVID-19): relationship to duration of infection"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 Novel Coronavirus (COVID-19) Pneumonia"},{"title3":"Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT"},{"title3":"Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients"},{"title3":"Imaging of pulmonary viral pneumonia"},{"title3":"Radiologic, pathologic, clinical, and physiologic findings of electronic cigarette or vaping product use-associated lung Injury (EVALI): evolving knowledge and remaining questions"},{"title3":"Drug-induced lung disease: high-resolution CT findings"},{"title3":"Imaging of cancer immunotherapy: current approaches and future directions"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Acute pulmonary injury: high-resolution CT and histopathological spectrum"},{"title3":"Imaging profile of the COVID-19 infection: radiologic findings and literature review"},{"title3":"Temporal Changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study"},{"title3":"Emerging 2019 Novel Coronavirus (2019-nCoV) pneumonia"},{"title3":"Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review"},{"title3":"Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"Chest CT findings in cases from the cruise ship &quot;Diamond Princess&quot; with coronavirus disease 2019 (COVID-19)"},{"title3":"Sensitivity of chest CT for COVID-19: Comparison to RT-PCR"},{"title3":"Laboratory diagnosis of emerging human coronavirus infections - The State of the Art"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"Fleischner society: glossary of terms for thoracic imaging"}]},{"title2":"KDIGO clinical practice guideline for acute kidney injury","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"China medical treatment expert group for C. cmorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis","References":[]},{"title2":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","References":[{"title3":"Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Tuberculosis and diabetes mellitus: convergence of two epidemics"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA Score"},{"title3":"Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011-2012: Hospital-based Influenza Morbidity &amp; Mortality (HIMM) surveillance"},{"title3":"Summary of the 2018 report on cardiovascular diseases in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Burden of diabetes, hyperglycaemia in China from to 2016: findings from the 1990 to 2016, global burden of disease study"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis"},{"title3":"Connecting type 1 and type 2 diabetes through innate immunity"},{"title3":"Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak - United States, December 31, 2019-February 4, 2020"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China, 2020"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","References":[{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19"},{"title3":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors"},{"title3":"Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and prostate cancer susceptibility"},{"title3":"Cell entry mechanisms of SARS-CoV-2"},{"title3":"Tissue ACE phenotyping in prostate cancer"},{"title3":"Effects of the angiotensin-I-converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells"},{"title3":"Clinical characteristics and results of semen tests among men with coronavirus disease 2019"},{"title3":"Role of proprotein convertases in prostate cancer progression"},{"title3":"Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells"},{"title3":"Inflammation-induced oxidative stress mediates gene fusion formation in prostate cancer"},{"title3":"Androgens and androgen receptor signaling in prostate tumorigenesis"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2"},{"title3":"The trinity of COVID-19: immunity, inflammation and intervention"},{"title3":"Epigenetic impact of infection on carcinogenesis: mechanisms and applications"},{"title3":"Prostate cancer and inflammation: the evidence"}]},{"title2":"Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease","References":[{"title3":"Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"The angiotensin-converting enzyme gene family: genomics and pharmacology"},{"title3":"Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism"},{"title3":"Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse"},{"title3":"ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes"},{"title3":"Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene"},{"title3":"A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload"},{"title3":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase"},{"title3":"Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys"},{"title3":"A protein complex in the brush-border membrane explains a Hartnup disorder allele"},{"title3":"Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain"},{"title3":"Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling"},{"title3":"Tissue renin-angiotensin systems: their role in cardiovascular disease"},{"title3":"Renin-angiotensin system and atherothrombotic disease: from genes to treatment"},{"title3":"Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice"},{"title3":"Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis"},{"title3":"ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice"},{"title3":"Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells"},{"title3":"Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase"},{"title3":"Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall"},{"title3":"Progression of cardiovascular damage: the role of renin-angiotensin system blockade"},{"title3":"Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function"},{"title3":"Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions"},{"title3":"Characterization of renal angiotensin:converting enzyme 2 in diabetic nephropathy"},{"title3":"Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats"},{"title3":"Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-l-arginine methyl ester"},{"title3":"Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice"},{"title3":"Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages"},{"title3":"Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats"},{"title3":"Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension"},{"title3":"Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation"},{"title3":"Injections of angiotensin-converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats"},{"title3":"Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure"},{"title3":"The renin-angiotensin system and volume overload-induced changes in cardiac collagen and elastin"},{"title3":"Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure"},{"title3":"Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial infarction"},{"title3":"Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro"},{"title3":"Direct evidence for increased hydroxyl radicals in angiotensin II-induced cardiac hypertrophy through angiotensin II type 1a receptor"},{"title3":"Structural remodeling in hypertensive heart disease and the role of hormones"},{"title3":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction:results of the survival and ventricular enlargement trial"},{"title3":"Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart"},{"title3":"The angiotensin converting enzyme 2/Ang-(1-7) axis in the heart: a role for mas communication?"},{"title3":"Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction"},{"title3":"Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47phox NADPH oxidase subunit"},{"title3":"Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II"},{"title3":"Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice"},{"title3":"Genetic manipulation of the renin-angiotensin system"},{"title3":"The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules"},{"title3":"Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis"},{"title3":"Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2"},{"title3":"ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice"},{"title3":"Loss of Angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury"},{"title3":"Renal ACE2 expression in human kidney disease"},{"title3":"Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis"},{"title3":"Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis"},{"title3":"ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR"},{"title3":"Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function"},{"title3":"Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension"},{"title3":"Human recombinant ACE2 reduces the progression of diabetic nephropathy"},{"title3":"Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition"},{"title3":"Chylomicron-remnant-like particles inhibit the basal nitric oxide pathway in porcine coronary artery and aortic endothelial cells"},{"title3":"Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction"},{"title3":"Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme homologue ACE2"},{"title3":" beta1 integrins expression in adult rat ventricular myocytes and its role in the regulation of beta-adrenergic receptor-stimulated apoptosis"},{"title3":"Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins"},{"title3":"Onset of experimental severe cardiac fibrosis is mediated by overexpression of Angiotensin-converting enzyme 2"},{"title3":"Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology"},{"title3":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction"},{"title3":"The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells"},{"title3":"Acute and chronic angiotensin-(1-7) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats"},{"title3":"Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats"},{"title3":"Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents"},{"title3":"Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases"},{"title3":"Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension"},{"title3":"ACE2 activation promotes antithrombotic activity"}]},{"title2":"Clinical features and short-term outcomes of 144 patients with SARS in the greater toronto area","References":[]},{"title2":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","References":[{"title3":"Angiotensinconverting enzyme 2 is an essential regulator of heart function"},{"title3":"The role of ACE2 in cardiovascular physiology"},{"title3":"Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice"},{"title3":"Loss of angiotensinconverting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Deletion of angiotensinconverting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II"},{"title3":"Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"ACE2: from vasopeptidase to SARS virus receptor"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"The severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus"},{"title3":"Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study"},{"title3":"Cardiovascular complications of severe acute respiratory syndrome"},{"title3":"Verapamil ameliorates the clinical and pathological course of murine myocarditis"},{"title3":"Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice"},{"title3":"Widespread myocardial inflammation and infarct-related artery patency"},{"title3":"Severe acute respiratory syndrome-associated coronavirus in lung tissue"},{"title3":"Pulmonary pathology of severe acute respiratory syndrome in Toronto"},{"title3":"A novel angiotensinconverting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Detection of SARS coronavirus in plasma by real-time RT-PCR"},{"title3":"Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells"},{"title3":"Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry"},{"title3":"Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2"},{"title3":"Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling"},{"title3":"Myocarditis: current trends in diagnosis and treatment"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Human immunopathogenesis of severe acute respiratory syndrome (SARS)"},{"title3":"Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling"}]},{"title2":"Cardiac tamponade secondary to COVID-19","References":[{"title3":"The variety of cardiovascular presentations of COVID-19"},{"title3":"Cardiac tamponade and massive pleural effusion in a young COVID-19-positive adult"},{"title3":"Pericarditis in patients with COVID-19: A systematic review"},{"title3":"Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)"},{"title3":"Coronavirus disease 2019 (COVID-19): A systematic review of imaging findings in 919 patients"},{"title3":"COVID-19 and the cardiovascular system"},{"title3":"Acute myopericarditis with pericardial effusion and cardiac tamponade in a patient with COVID-19"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"ACE2: From vasopeptidase to SARS virus receptor"},{"title3":"Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic"},{"title3":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease: A vicious circle"},{"title3":"COVID-19 myopericarditis with cardiac tamponade in the absence of respiratory symptoms: A case report"},{"title3":"Coronavirus disease 2019 (COVID-19) CT findings: A systematic review and meta-analysis"},{"title3":"Acute pericarditis and cardiac tamponade in a patient with COVID-19: A therapeutic challenge"},{"title3":"Cardiac tamponade secondary to COVID-19"},{"title3":"Acute perimyocarditis with cardiac tamponade in COVID-19 infection without respiratory disease"},{"title3":"Acute life-threatening cardiac tamponade in a mechanically ventilated patient with COVID-19 pneumonia"},{"title3":"SARS-CoV-2 detection in the pericardial fluid of a patient with cardiac tamponade"},{"title3":"Cardiac tamponade in a patient with myocardial infarction and COVID-19: Electron microscopy"},{"title3":"Cardiac tamponade in COVID-19 patients: Management and outcomes"},{"title3":"Hemorrhagic pericardial effusion leading to cardiac tamponade, as presenting feature of COVID-19 in a young man: A case report"},{"title3":"Coronavirus disease 2019 (COVID-19) and severe pericardial effusion: From pathogenesis to management: A case report based systematic review"},{"title3":"Coronavirus disease 2019 (Covid-19) presenting as purulent fulminant myopericarditis and cardiac tamponade: A case report and literature review"},{"title3":"A rare presentation of a patient with COVID-19: cardiac tamponade"},{"title3":"Dry'pericarditis with rapid progression to tamponade as a feature of COVID-19"},{"title3":"Cardiac tamponade as a cause of COVID-19"},{"title3":"Cardiac tamponade as a cause of cardiac arrest in severe COVID-19 pneumonia"},{"title3":"Pericardial effusion in patients with COVID-19: Case series"},{"title3":"A case of hemorrhagic cardiac tamponade in a patient with COVID-19 infection"},{"title3":"A rare case of COVID-19 myocarditis with cardiac tamponade in a young diabetic adult with renal failure"},{"title3":"Pericardial effusion and cardiac tamponade requiring pericardial window in an otherwise healthy 30-year-old patient with COVID-19: A case report"},{"title3":"Comparative study of subxiphoid versus video-thoracoscopic pericardial &quot;window&quot;"},{"title3":"VATS pericardiotomy for patients with known malignancy and pericardial effusion: survival and prognosis of positive cytology and metastatic involvement of the pericardium: A case control study"},{"title3":"Cardiac tamponade caused by acute coxsackievirus infection related pericarditis complicated by aortic stenosis in a hemodialysis patient: A case report"}]},{"title2":"First case of COVID-19 complicated with fulminant myocarditis: a case report and insights","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis"},{"title3":"An experimental model for myocarditis and congestive heart failure after rabbit coronavirus infection"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"A follow-up study of 69 discharged SARS patients"},{"title3":"Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"Intermittent hypoxia causes inflammation and injury to human adult cardiac myocytes"},{"title3":"Prognostic value of electrocardiography in patients with fulminant myocarditis supported by percutaneous venoarterial extracorporeal membrane oxygenation:analysis from the CHANGE PUMP study"}]},{"title2":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","References":[]},{"title2":"High-sensitivity troponin T is an important independent predictor in addition to the simplified acute physiology score for short-term ICU mortality, particularly in patients with sepsis","References":[]},{"title2":"Myocardial injury in patients with sepsis and its association with long-term outcome","References":[]},{"title2":"High-sensitivity cardiac troponin T is an independent predictor of inhospital mortality in emergency department patients with suspected infection: a prospective observational derivation study","References":[]},{"title2":"The coagulopathy of acute sepsis","References":[{"title3":"Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study"},{"title3":"Characteristics, treatments, and outcomes of severe sepsis of 3195 ICU-treated adult patients throughout Japan during 2011-2013"},{"title3":"Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan"},{"title3":"Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan"},{"title3":"Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation"},{"title3":"Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation"},{"title3":"Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials"},{"title3":"A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria"},{"title3":"Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Revision of the Japanese Association for Acute Medicine (JAAM)-disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity"},{"title3":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition"},{"title3":"Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis"},{"title3":"Retrospective description and experimental reconstitution of three different responses of the baboon to lethal E. coli "},{"title3":"Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey"},{"title3":"Disseminated intravascular coagulation (DIC) diagnosed based on the Japanese Association for Acute Medicine criteria is a dependent continuum to overt DIC in patients with sepsis"},{"title3":"Disseminated intravascular coagulation"},{"title3":"Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan"},{"title3":"Expert consensus for the treatment of disseminated intravascular coagulation in Japan"},{"title3":"Addition of recommendations for the use of recombinant human thrombomodulin to the &quot;Expert consensus for the treatment of disseminated intravascular coagulation in Japan"},{"title3":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},{"title3":"Should all patients with sepsis receive anticoagulation? Yes"},{"title3":"Should all septic patients be given systemic anticoagulation? No"},{"title3":"Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis"},{"title3":"Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis"},{"title3":"Fibrinolysis in disseminated intravascular coagulation"}]},{"title2":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","References":[{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Frequency of thrombocytopenia and heparin-induced thrombocytopenia in patients receiving extracorporeal membrane oxygenation compared with cardiopulmonary bypass and the limited sensitivity of pretest probability score"},{"title3":"Intracranial hemorrhage and early mortality in patients receiving extracorporeal membrane oxygenation for severe respiratory failure"}]},{"title2":"Kawasaki-like disease: emerging complication during the COVID-19 pandemic","References":[{"title3":"Coronavirus Disease 2019 in Children:United States, February 12-April 2, 2020"},{"title3":"Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol"},{"title3":"Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China"},{"title3":"Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study"},{"title3":"Epidemiology of COVID-19 among children in China"},{"title3":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study"},{"title3":"Dissecting Kawasaki disease: a state-of-the-art review"},{"title3":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association"},{"title3":"Guidance:Paediatric multisystem inflammatory syndrome temporally associated with COVID-19"},{"title3":"Hyperinflammatory shock in children during COVID-19 pandemic"}]},{"title2":"ST-Segment elevation in patients with covid-19 : a case series","References":[]}]},{"title1":"Prognostic Value of Elevated Cardiac Troponin I in Hospitalized Covid-19 Patients","References":[{"title2":"World Health Organization. Coronavirus disease (COVID-19) Situation Report - 151. Available athttps://www.who.int/docs/default-source/coronaviruse/situation-reports/20200619-covid-19-sitrep-151.pdf?sfvrsn=8b23b56e_2 (Accessed on June 20, 2020).","References":[]},{"title2":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","References":[{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19"},{"title3":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors"},{"title3":"Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and prostate cancer susceptibility"},{"title3":"Cell entry mechanisms of SARS-CoV-2"},{"title3":"Tissue ACE phenotyping in prostate cancer"},{"title3":"Effects of the angiotensin-I-converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells"},{"title3":"Clinical characteristics and results of semen tests among men with coronavirus disease 2019"},{"title3":"Role of proprotein convertases in prostate cancer progression"},{"title3":"Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells"},{"title3":"Inflammation-induced oxidative stress mediates gene fusion formation in prostate cancer"},{"title3":"Androgens and androgen receptor signaling in prostate tumorigenesis"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2"},{"title3":"The trinity of COVID-19: immunity, inflammation and intervention"},{"title3":"Epigenetic impact of infection on carcinogenesis: mechanisms and applications"},{"title3":"Prostate cancer and inflammation: the evidence"}]},{"title2":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","References":[]},{"title2":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Coronavirus infections: more than just the common cold"},{"title3":"Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Published December 31, 2019. Accessed January 31, 2020. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":" Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Published March 13, 2020. Accessed January 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected"},{"title3":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"A Novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"}]},{"title2":"Cardiac troponin I is an independent predictor for mortality in hospitalized patients with coronavirus disease 2019","References":[]},{"title2":"Demographics, comorbidities, and outcomes in hospitalized covid-19 patients in rural Southwest Georgia","References":[]},{"title2":"Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection","References":[{"title3":"COVID-19, ACE2, and the cardiovascular consequences"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)"},{"title3":"First case of COVID-19 complicated with fulminant myocarditis: a case report and insights"},{"title3":"Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin"},{"title3":"Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis"},{"title3":"R: a language and environment for statistical computing. R Foundation for Statistical Computing. 2017"},{"title3":"Survminer: drawing survival curves using &quot;ggplot2.&quot; 2019"},{"title3":"cmprsk: subdistribution analysis of competing risks. 2019"},{"title3":"The variety of cardiovascular presentations of COVID-19"},{"title3":"Fourth universal definition of myocardial infarction (2018)"},{"title3":"Cardiac troponins: from myocardial infarction to chronic disease"},{"title3":"Trivializing an Elevated Troponin: Adding Insult to Injury?"},{"title3":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases"},{"title3":"COVID-19 autopsies, Oklahoma, USA"},{"title3":"Myocardial localization of coronavirus in COVID-19 cardiogenic shock"},{"title3":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease"},{"title3":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?"},{"title3":"Potential effects of coronaviruses on the cardiovascular system: a review"},{"title3":"ST-segment elevation in patients with Covid-19:a case series"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19"},{"title3":"Pleiotropic vascular protective effects of statins in perioperative medicine"},{"title3":"Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality"},{"title3":"Statins and cardioprotection:more than just lipid lowering?"},{"title3":"Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission"}]},{"title2":"Acute myocardial injury at hospital admission is associated with all-cause mortality in COVID-19","References":[{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Chinese management guideline for COVID-19 (version 7.0)"},{"title3":"Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)"}]},{"title2":"Myocardial injury and COVID-19: possible mechanisms","References":[{"title3":"Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19"},{"title3":"Cardiac Injury Patterns and Inpatient Outcomes Among Patients Admitted With COVID-19"},{"title3":"Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China"},{"title3":"Association between myocardial injury and prognosis of COVID-19 hospitalized patients, with or without heart disease. CARDIOVID registry"},{"title3":"Fourth Universal Definition of Myocardial Infarction (2018)"},{"title3":"COVID-19-related myocarditis in a 21-year-old female patient"},{"title3":"First case of COVID-19 complicated with fulminant myocarditis: a case report and insights"},{"title3":"Myocarditis in COVID-19 patients: current problems"},{"title3":"Takotsubo Syndrome in Patients with COVID-19: a Systematic Review of Published Cases"},{"title3":"Correlation between takotsubo cardiomyopathy and SARS-CoV-2 infection"},{"title3":"Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction"},{"title3":"Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19"},{"title3":"Acute Coronary Syndrome in the Era of SARS-CoV-2 Infection: A Registry of the French Group of Acute Cardiac Care"},{"title3":"Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19"},{"title3":"Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis"},{"title3":"Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis"},{"title3":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system"},{"title3":"Variants in ACE2; potential influences on virus infection and COVID-19 severity"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)"},{"title3":"Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes"},{"title3":"Myocardial localization of coronavirus in COVID-19 cardiogenic shock"},{"title3":"Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies"},{"title3":"SARS-Cov-2 fulminant myocarditis: an autopsy and histopathological case study"},{"title3":"Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases"},{"title3":"SARS-CoV-2 leads to a small vessel endotheliitis in the heart"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"},{"title3":"Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science"},{"title3":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"Ca2+ Ions Promote Fusion of Middle East Respiratory Syndrome Coronavirus with Host Cells and Increase Infectivity"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component"},{"title3":"ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19"},{"title3":"Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2"},{"title3":"Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients"},{"title3":"The SARS-CoV Fusion Peptide Forms an Extended Bipartite Fusion Platform that Perturbs Membrane Order in a Calcium-Dependent Manner"},{"title3":"Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis"},{"title3":"Angiotensin converting enzyme-2 (ACE2) and its possible roles in hypertension, diabetes and cardiac function"},{"title3":"Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration"},{"title3":"COVID-19 and the cardiovascular system"},{"title3":"Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS"},{"title3":"The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy"},{"title3":"Age-associated pro-inflammatory remodeling and functional phenotype in the heart and large arteries"},{"title3":"Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction"},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China"},{"title3":"Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions"},{"title3":"Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice"},{"title3":"Potential role of interferons in treating COVID-19 patients"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice"},{"title3":"Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses"},{"title3":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon"},{"title3":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19"},{"title3":"Into the eye of the cytokine storm"},{"title3":"Convalescent plasma in Covid-19: Possible mechanisms of action"},{"title3":"An inflammatory cytokine signature predicts COVID-19 severity and survival"},{"title3":"High Inflammatory Burden: A Potential Cause of Myocardial Injury in Critically Ill Patients With COVID-19"},{"title3":"COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?"},{"title3":"Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality"},{"title3":"Targeting Interleukin-6 Signaling in Clinic"},{"title3":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies"},{"title3":"COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection"},{"title3":"Bidirectional relation between inflammation and coagulation"},{"title3":"The role of ADAMTS-13 in the coagulopathy of sepsis"},{"title3":"The role of tissue factor and factor VIIa in hemostasis"},{"title3":"Role of tissue factor in hemostasis, thrombosis, and vascular development"},{"title3":"Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases"},{"title3":"Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis"},{"title3":"Neutrophil extracellular traps and thrombosis in COVID-19"},{"title3":"Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis"},{"title3":"Mitochondrial reactive oxygen species-mediated signaling in endothelial cells"},{"title3":"Hypoxia and aerobic metabolism adaptations of human endothelial cells"},{"title3":"Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha"},{"title3":"Crosstalk between inflammation and coagulation: the lessons of sepsis"},{"title3":"Activation of NLRP3 inflammasome complex potentiates venous thrombosis in response to hypoxia"},{"title3":"Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation"},{"title3":"Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series"},{"title3":"Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target"},{"title3":"Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019"},{"title3":"COVID-19 and Cardiovascular Disease"},{"title3":"Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial"},{"title3":"Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients"},{"title3":"A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers"},{"title3":"Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19"},{"title3":"Sarilumab vs standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial"},{"title3":"Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial"},{"title3":"Anti-inflammatory therapy for COVID-19 infection: the case for colchicine"},{"title3":"Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial"},{"title3":"Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial"},{"title3":"Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome"},{"title3":"Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report"},{"title3":"American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19"},{"title3":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19"},{"title3":"Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum"},{"title3":"COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET)"},{"title3":"Effect of antiplatelet treatments on patients with COVID-19 infection: A systematic review and meta-analysis"},{"title3":"SARS-CoV-2 Receptors are Expressed on Human Platelets and the Effect of Aspirin on Clinical Outcomes in COVID-19 Patients"},{"title3":"Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19?"},{"title3":"The effect of prostacyclin (Iloprost) infusion at a dose of 1 ng/kg/min for 72 hours compared to placebo in mechanically ventilated patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial"},{"title3":"Protocol for a randomized controlled trial testing inhaled nitric oxide therapy in spontaneously breathing patients with COVID-19"},{"title3":"Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients"},{"title3":"Statin use and clinical outcomes in patients with COVID-19: An updated systematic review and meta-analysis"},{"title3":"The liver in times of COVID-19: What hepatologists should know"},{"title3":"Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)"},{"title3":"Intermediate vs standard-dose prophylactic anticoagulation and statin therapy vs placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies"},{"title3":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects"},{"title3":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome"},{"title3":"Recombinant human ACE2: acing out angiotensin II in ARDS therapy"},{"title3":"miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19"}]},{"title2":"COVID-19 cardiac injury: implications for long-term surveillance and outcomes in survivors","References":[{"title3":"COVID-19 and the cardiovascular system"},{"title3":"Covid-19 in critically Ill patients in the Seattle region:case series"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China [published online ahead of print March 25, 2020]. JAMA Cardiol"},{"title3":"Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management [published online ahead of print May 5, 2020]. Heart Rhythm"},{"title3":"COVID-19 and the heart"},{"title3":"The science underlying COVID-19: implications for the cardiovascular system"},{"title3":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2"},{"title3":"From inflammation to fibrosis-molecular and cellular mechanisms of myocardial tissue remodelling and perspectives on differential treatment opportunities"},{"title3":"Compassionate use of remdesivir for patients with severe Covid-19"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) [published online ahead of print March 27, 2020]. JAMA Cardiol"},{"title3":"Bonow RO, Fonarow GC, O'Gara PT, Yancy CW. Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality [published online ahead of print March 27, 2020]. JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.1105."},{"title3":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) [published online ahead of print March 27, 2020]. JAMA Cardiol"},{"title3":"COVID-19 for the cardiologist: a current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of Covid-19 in New York City"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Myocardial localization of coronavirus in COVID-19 cardiogenic shock"},{"title3":"Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: clinical evidence and molecular mechanisms"},{"title3":"ST-segment elevation in patients with Covid-19:a case series"},{"title3":"Acute myocardial infarction after laboratory-confirmed influenza infection"},{"title3":"Management of acute myocardial infarction during the COVID-19 pandemic [published online ahead of print April 21, 2020]. J Am Coll Cardiol"},{"title3":"Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury"},{"title3":"Persistent long-term structural, functional, and metabolic changes after stress-induced (takotsubo) cardiomyopathy"},{"title3":"Ventricular arrhythmias and sudden cardiac arrest in Takotsubo cardiomyopathy: incidence, predictive factors, and clinical implications"},{"title3":"Coronary microembolization and microvascular dysfunction"},{"title3":"Predictors of long-term outcome in patients with biopsy proven inflammatory cardiomyopathy"},{"title3":"Ventricular arrhythmias in myocarditis: characterization and relationships with myocardial inflammation"},{"title3":"Heart failure and mortality of adult survivors from acute myocarditis requiring intensive care treatment:a nationwide cohort study"},{"title3":"Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors"},{"title3":"Long-term evolution and prognostic stratification of biopsy-proven active myocarditis"},{"title3":"Successful use of a wearable cardioverter-defibrillator in myocarditis with normal ejection fraction"},{"title3":"Temporal trends in the clinical and pathological characteristics of victims of sudden cardiac death in the absence of previously identified heart disease"},{"title3":"Prospective countywide surveillance and autopsy characterization of sudden cardiac death: POST SCD study"},{"title3":"Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006"},{"title3":"Ventricular myocarditis coincides with atrial myocarditis in patients"},{"title3":"Myocardial biopsy in &quot;idiopathic&quot; atrial fibrillation and other arrhythmias: nosological diagnosis, clinical and morphological parallels, and treatment"},{"title3":"The association between influenza infection, vaccination, and atrial fibrillation: a nationwide case-control study"},{"title3":"Targeting the adipose tissue in COVID-19"},{"title3":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium"},{"title3":"Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects"}]},{"title2":"Fourth universal definition of myocardial infarction (2018)","References":[{"title3":"Upsloping ST depression: Is it acute ischemia?"},{"title3":"LVH and the diagnosis of STEMI - how should we apply the current guidelines?"},{"title3":"The role of the ECG in diagnosis, risk estimation, and catheterization laboratory activation in patients with acute coronary syndromes: A consensus document"},{"title3":"ST segment depression in a VL: A sensitive marker for acute inferior myocardial infarction"},{"title3":"ECG diagnosis and classification of acute coronary syndromes"},{"title3":"ST-segment elevation soon after coronary artery bypass"},{"title3":"Negative T wave in ischemic heart disease: A consensus article"},{"title3":"Prevalence of junctional ST-depression with tall symmetrical T-waves in a pre-hospital field triage system for STEMI patients"},{"title3":"Precordial junctional ST-segment depression with tall symmetric T-waves signifying proximal LAD occlusion, case reports of STEMI equivalence"},{"title3":"A New ECG Sign of Proximal LAD Occlusion"},{"title3":"Aborted infarction: The ultimate myocardial salvage"},{"title3":"ST elevation: differentiation between ST elevation myocardial infarction and nonischemic ST elevation"},{"title3":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)"},{"title3":"Utility of left bundle branch block as a diagnostic criterion for acute myocardial infarction"},{"title3":"Cardiac Magnetic Resonance Evaluation of the Extent of Myocardial Injury in Patients with Inferior ST Elevation Myocardial Infarction and Concomitant ST Depression in Leads V1-V3: Analysis from the MITOCARE Study"},{"title3":"Acute coronary syndromes presenting with transient diffuse ST segment depression and st segment elevation in lead aVR not caused by &quot;acute left main coronary artery occlusion&quot;: Description of two cases"},{"title3":"Recommendations for the standardization and interpretation of the electrocardiogram: Part I: The electrocardiogram and its technology: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: Endorsed by the International Society for Computerized Electrocardiology"},{"title3":"Diffuse ST depression with ST elevation in aVR: Is this pattern specific for global ischemia due to left main coronary artery disease?"},{"title3":"ST segment elevation following coronary artery bypass surgery"},{"title3":"Modification of ACC/ESC criteria for acute myocardial infarction"},{"title3":"Racial differences in the ECG-selected aspects"},{"title3":"Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-9: &quot;hidden&quot; ST-segment elevations revealing acute posterior infarction"},{"title3":"Prevalence and Clinical Significance of Up-Sloping ST-Segment Depression in Patients With Non-ST-Segment Elevation Myocardial Infarction"},{"title3":"Right bundle branch block in patients with suspected myocardial infarction"},{"title3":"2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines"},{"title3":"The value of upsloping ST depression in diagnosing myocardial ischemia"},{"title3":"Are there differences among patients with inferior acute myocardial infarction with ST depression in leads V2 and V3 and positive versus negative T waves in these leads on admission?"},{"title3":"Clinical significance of upsloping ST segments in exercise electrocardiography"},{"title3":"Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators"},{"title3":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation"},{"title3":"Fourth universal definition of myocardial infarction (2018)"},{"title3":"Is The Diagnosis ST-Segment Elevation or Non-ST-Segment Elevation Myocardial Infarction?"},{"title3":"Persistent precordial &quot;hyperacute&quot; T-waves signify proximal left anterior descending artery occlusion"},{"title3":"Pitfalls in diagnosing ST elevation among patients with acute myocardial infarction"},{"title3":"Primary angioplasty in acute myocardial infarction with right bundle branch block: Should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy?"},{"title3":"Recommendations for Standardization of Electrocardiographic and Vectorcardiographic Leads"}]}]}]}